// App-Quantinova.ai

PB2432 : ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban

Researchers

Presenter

  • M. Schindewolf

Principal Investigators

  • B. Brggenjrgen

  • C. Ay

  • P. Hainaut

  • U. Hoffmann

  • S. Gaine

  • M. Coppens

  • D. Jimnez

  • P. Levy

  • J. Lpez Bastida

  • E. Vicaut

  • P. Bramlage

  • G. Agnelli

  • A.T. Cohen

Medical Centers

  • University of Bern, Bern University Hospital, Division of Angiology, Bern, Switzerland

  • Steinbeis-University, Institute for Health Economics, Berlin, Germany

  • Medical Univ. of Vienna, Department of Medicine I, Vienna, Austria

  • Cliniques Universitaires Saint Luc, UCL, Internal Medicine, Brussels, Belgium

  • Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Division of Angiology, Munich, Germany

  • Mater Misericordiae University Hospital, National Pulmonary Hypertension Unit, Dublin, Ireland

  • Amsterdam University Medical Center, location AMC, Department of Pediatric Hematology, Amsterdam, the Netherlands

  • Ramon y Cajal University Hospital, Madrid, Spain

  • LEGOS, Université Paris - Dauphine, Paris, France

  • University of Castilla-La Mancha, Toledo, Spain

  • Université Paris Descartes,Faculty of Medicine, Paris, France

  • Institute for Pharmacology and Preventive Medicine, Mahlow, Germany

  • University of Perugia, Internal and Cardiovascular Medicine – Stroke Unit, Perugia, Italy

  • King's College London, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

Locations

  • Switzerland

  • Germany

  • Austria

  • Belgium

  • Ireland

  • Netherlands

  • Spain

  • France

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Body mass index

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved